Pharmacogenomic Studies of Antiviral Drug Favipiravir

• Egile Nagusiak: Victoria V. Shumyantseva (Egilea), Tatiana V. Bulko (Egilea), Alexey A. Chistov (Egilea), Ekaterina F. Kolesanova (Egilea), Lyubov E. Agafonova (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

In this work, we conducted a study of the interaction between DNA and favipiravir (FAV). This chemotherapeutic compound is an antiviral drug for the treatment of COVID-19 and other infections caused by RNA viruses. This paper examines the electroanalytical characteristics of FAV. The determined conc...